BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership Changes & 13F Activity
BRIDGEBIO PHARMA INC (BBIO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Viking Global Investors, Citadel Advisors Llc, Janus Henderson Group Plc, Polar Capital Holdings Plc, and Two Sigma Investments, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| M&T Bank Corp | Sell | -381,010 | -98.2% | 7,009 | $520.93K | Q1 2026 | Sep 04, 2026 |
| Cornerstone Financial Management Llc | Buy | +7 | — | 7 | $520.00 | Q1 2026 | Aug 28, 2026 |
| Ensign Peak Advisors, Inc | Sell | -426,932 | -33.8% | 836,552 | $62.12M | Q1 2026 | Aug 18, 2026 |
| Torno Capital, Llc | Sell | -2,500 | -100.0% | 0 | $0.00 | Q1 2026 | Aug 17, 2026 |
| Mirae Asset Global Investments Co., Ltd. | Buy | +7,813 | +79.4% | 17,647 | $1.31M | Q1 2026 | Aug 12, 2026 |
| Algert Global Llc | Sell | -57,127 | -16.8% | 283,921 | $21.08M | Q1 2026 | Aug 11, 2026 |
| Pier 88 Investment Partners Llc | Buy | +7,700 | — | 7,700 | $571.80K | Q1 2026 | Jul 31, 2026 |
| Wells Fargo & Company/Mn | Sell | -99,722 | -42.9% | 132,540 | $9.84M | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +207,700 | +19.3% | 1,285,748 | $95.48M | Q1 2026 | May 18, 2026 |
| Adar1 Capital Management, Llc | Sell | -119,122 | -55.8% | 94,292 | $7.00M | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Buy | +31,797 | +23.7% | 165,703 | $12.31M | Q1 2026 | May 18, 2026 |
| Amundi | Buy | +7,954 | +170.8% | 12,610 | $936.42K | Q1 2026 | May 18, 2026 |
| Sunbelt Securities, Inc. | Buy | +135 | +4500.0% | 138 | $10.25K | Q1 2026 | May 18, 2026 |
| Viking Global Investors | Sell | -2,551,500 | -17.7% | 11,842,434 | $879.42M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Buy | +2,475,758 | +354.6% | 3,173,940 | $235.70M | Q1 2026 | May 15, 2026 |
| Janus Henderson Group Plc | Buy | +2,178,556 | +19.8% | 13,179,013 | $978.61M | Q1 2026 | May 15, 2026 |
| Polar Capital Holdings Plc | Buy | +1,219,960 | +93.9% | 2,519,306 | $187.08M | Q1 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Buy | +1,173,584 | +60.3% | 3,120,631 | $231.74M | Q1 2026 | May 15, 2026 |
| Millennium Management Llc | Buy | +596,698 | +1631.0% | 633,283 | $47.03M | Q1 2026 | May 15, 2026 |
| Driehaus Capital Management Llc | Sell | -534,301 | -31.8% | 1,146,671 | $85.15M | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +505,507 | +11.5% | 4,918,030 | $371.93M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +477,550 | +34.1% | 1,877,359 | $139.41M | Q1 2026 | May 15, 2026 |
| Summit Partners Public Asset Management, Llc | Sell | -460,963 | -56.6% | 352,831 | $26.20M | Q1 2026 | May 15, 2026 |
| Cormorant Asset Management, Lp | Sell | -350,000 | -29.2% | 850,000 | $63.12M | Q1 2026 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +331,455 | +15.0% | 2,545,486 | $189.03M | Q1 2026 | May 15, 2026 |
| Sofinnova Investments, Inc. | Sell | -311,265 | -43.2% | 409,183 | $30.39M | Q1 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Buy | +287,425 | +106.9% | 556,324 | $41.31M | Q1 2026 | May 15, 2026 |
| Integral Health Asset Management, Llc | Buy | +275,000 | — | 275,000 | $20.42M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Buy | +259,696 | +347.7% | 334,382 | $24.83M | Q1 2026 | May 15, 2026 |
| Engineers Gate Manager Lp | Buy | +228,155 | +1465.0% | 243,729 | $18.10M | Q1 2026 | May 15, 2026 |
Frequently asked questions about BBIO activity
Which institutional owners are buying BBIO?
Institutional owners buying BBIO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BBIO activity?
"Buy" means an investor increased their reported position in BBIO compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO PHARMA INC (BBIO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BBIO increasing?
Institutional interest in BBIO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BBIO Institutional Insights
- BBIO Overview
- BBIO 13F Institutional Holders
- BBIO Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BBIO Insider Trading & SEC Form 4 Activity
- BBIO Articles
- Top Institutional Investor Stock Rankings